Biomedical Engineering Reference
In-Depth Information
233. Mazo M, Pelacho B, Prosper F (2010) Stem cell therapy for chronic myocardial infarction.
J Cardiovasc Transl Res 3(2):79-88
234. Menasche P (2009) Stem cell therapy for heart failure: are arrhythmias a real safety
concern? Circulation 119(20):2735-2740
235. Huang
NF,
Li
S
(2011)
Regulation
of
the
matrix
microenvironment
for
stem
cell
engineering and regenerative medicine. Ann Biomed Eng 39(4):1201-1214
236. Bouten CV, Dankers PY, Driessen-Mol A, Pedron S, Brizard AM, Baaijens FP (2011)
Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev 63(4-5):221-241
237. O'Shaughnessy
L
(1937)
Surgical
treatment
of
cardiac
ischemia.
The
Lancet
229(5917):185-194
238. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM (2006) Theoretical impact of
the
injection
of
material
into
the
myocardium:
a
finite
element
model
simulation.
Circulation 114(24):2627-2635
239. Cortes-Morichetti M, Frati G, Schussler O, Van Duong JPH, Lauret E, Genovese JA,
Carpentier AF, Chachques JC (2007) Association between a cell-seeded collagen matrix and
cellular
cardiomyoplasty
for
myocardial
support
and
regeneration.
Tissue
Eng
13(11):2681-2687
240. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, Piao S, Lim SH, Hong YS, Choi CY,
Yoo KJ, Kim BS (2005) Implantation of bone marrow mononuclear cells using injectable
fibrin
matrix
enhances
neovascularization
in
infarcted
myocardium.
Biomaterials
26(3):319-326
241. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J
(2008) Effect of injectable alginate implant on cardiac remodeling and function after recent
and old infarcts in rat. Circulation 117(11):1388-1396
242. Leor J, Tuvia S, Guetta V, Manczur F, Castel D, Willenz U, Petnehazy O, Landa N,
Feinberg MS, Konen E, Goitein O, Tsur-Gang O, Shaul M, Klapper L, Cohen S (2009)
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular
remodeling after myocardial infarction in swine. J Am Coll Cardiol 54(11):1014-1023
243. Ruvinov E, Leor J, Cohen S (2011) The promotion of myocardial repair by the sequential
delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute
myocardial infarction. Biomaterials 32(2):565-578
244. Yu J, Gu Y, Du KT, Mihardja S, Sievers RE, Lee RJ (2009) The effect of injected RGD
modified alginate on angiogenesis and left ventricular function in a chronic rat infarct
model. Biomaterials 30(5):751-756
245. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, Zhang S, Lee
RT
(2005)
Injectable
self-assembling
peptide
nanofibers
create
intramyocardial
microenvironments for endothelial cells. Circulation 111(4):442-450
246. Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT (2005) Custom design of the cardiac
microenvironment with biomaterials. Circ Res 97(1):8-15
247. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT (2006) Controlled delivery of
PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers.
J Clin Invest 116(1):237-248
248. Padin-Iruegas ME, Misao Y, Davis ME, Segers VF, Esposito G, Tokunou T, Urbanek K,
Hosoda T, Rota M, Anversa P, Leri A, Lee RT, Kajstura J (2009) Cardiac progenitor cells
and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous
myocardial regeneration after infarction. Circulation 120(10):876-887
249. Lin YD, Yeh ML, Yang YJ, Tsai DC, Chu TY, Shih YY, Chang MY, Liu YW, Tang AC,
Chen TY, Luo CY, Chang KC, Chen JH, Wu HL, Hung TK, Hsieh PC (2010)
Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling
and efficacy of bone marrow cell therapy in pigs. Circulation 122(11 Suppl):S132-S141
250. Hernandez RM, Orive G, Murua A, Pedraz JL (2010) Microcapsules and microcarriers for
in situ cell delivery. Adv Drug Deliv Rev 62(7-8):711-730
